A team of researchers at Oregon Health & Science University (OHUSU; Eugene) and Washington University (St. Louis) say they have described for the first time the mechanism that gives a mutant enzyme molecule that they have engineered and patented with potential to become a breakthrough drug for treating heart attacks and strokes.

Mutant enzyme molecule possible basis for heart attack and stroke drugs

Name: Relias Media
Price range: $

January 2, 2015

Reprints

Recognizing, Managing, and Reporting Pediatric Sexual Abuse and Assault
Eleventh Circuit Affirms Jury Verdict of $2.5 Million for Mesh Device Plaintiff Despite Close Call on Statute of Limitations
Indiana Appellate Court Allows Case to Proceed Against Doctor Accused of Improperly Accessing Patients’ Medical Records
Malpractice Insurance Rates Increasing After Stable Period
Clinical Decision Software Highly Effective in OR